These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6109624)

  • 1. Potassium modification of the somatostatin effect on stimulated rat growth hormone release.
    Stachura ME
    Endocrinology; 1981 Mar; 108(3):1027-34. PubMed ID: 6109624
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of somatostatin inhibition and dibutyryl cyclic AMP or potassium stimulation of growth hormone release from perifused rat pituitaries.
    Stachura ME
    Endocrinology; 1977 Oct; 101(4):1044-53. PubMed ID: 198193
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of somatostatin: growth-hormone release and [45Ca]calcium ion translocation caused by increasing the extracellular potassium ion concentration [proceedings].
    Bicknell RJ; Schofield JG
    Biochem Soc Trans; 1977; 5(4):1051-3. PubMed ID: 913779
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of growth hormone from purified somatotrophs: use of perifusion system to elucidate interrelations among Ca++, adenosine 3',5'-monophosphate, and somatostatin.
    Kraicer J; Chow AE
    Endocrinology; 1982 Oct; 111(4):1173-80. PubMed ID: 6180887
    [No Abstract]   [Full Text] [Related]  

  • 6. Cofactor requirements for the stimulation of ox growth hormone release in vitro.
    Kerbey AL; McPherson M; Sheterline P; Schofield JG
    Symp Soc Exp Biol; 1974; (28):375-97. PubMed ID: 4375863
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of somatostatin and verapamil on growth hormone release and 45Ca fluxes.
    Schofield JG; Bicknell RJ
    Mol Cell Endocrinol; 1978 Jan; 9(3):255-68. PubMed ID: 624436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on action of somatostatin on growth hormone release in relation to calcium and cAMP.
    Hayasaki-Kimura N; Takahashi K
    Proc Soc Exp Biol Med; 1979 Jul; 161(3):312-8. PubMed ID: 223171
    [No Abstract]   [Full Text] [Related]  

  • 9. A study on the regulation of growth hormone release from the pituitaries of rats in vitro.
    Bowers CY; Reynolds GA; Chang D; Hong A; Chang K; Momany F
    Endocrinology; 1981 Mar; 108(3):1071-80. PubMed ID: 6109625
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRIF-sensitive compartmentalization of stored rGH is abolished by hypothyroidism.
    Stachura ME
    Mol Cell Endocrinol; 1986 Jan; 44(1):37-45. PubMed ID: 2868949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary immediate release pools of growth hormone and prolactin are preferentially refilled by new rather than stored hormone.
    Stachura ME; Tyler JM; Kent PG
    Endocrinology; 1989 Jul; 125(1):444-9. PubMed ID: 2544408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequestration of an early-release pool of growth hormone and prolactin in GH3 rat pituitary tumor.
    Stachura ME
    Endocrinology; 1982 Dec; 111(6):1769-77. PubMed ID: 6291898
    [No Abstract]   [Full Text] [Related]  

  • 14. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro effects of cholecystokinin octapeptide on the release of growth hormone in rats.
    Matsumura M; Yamanoi A; Yamamoto S; Mori H; Saito S
    Horm Metab Res; 1984 Dec; 16(12):626-30. PubMed ID: 6151935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional heterogeneity in somatotrophs isolated from the rat anterior pituitary.
    Snyder G; Hymer WC; Snyder J
    Endocrinology; 1977 Sep; 101(3):788-99. PubMed ID: 196832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responsiveness of the somatotroph to growth hormone-releasing factor during early neonatal development in the rat.
    Szabo M; Cuttler L
    Endocrinology; 1986 Jan; 118(1):69-73. PubMed ID: 3000750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
    Lamberts SW; den Holder F; Hofland LJ
    Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of somatostatin: inhibition of ionophore A23187-induced release of growth hormone from dispersed bovine pituitary cells.
    Bicknell RJ; Schofield JG
    FEBS Lett; 1976 Sep; 68(1):23-6. PubMed ID: 786734
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional substructure of the rat somatotroph immediate release pool: definition by responses to N6,2'-O-dibutyryl cyclic adenosine 3',5'-monophosphate, potassium ion, and/or prostaglandin E1.
    Stachura ME; Tyler JM
    Endocrinology; 1986 Nov; 119(5):2168-76. PubMed ID: 3021434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.